Search results
Results from the WOW.Com Content Network
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
President Benigno Aquino III at the launching of the dengue vaccine school-based immunization program. In April 2016, the DOH launched the dengue vaccination campaign in Central Luzon, Calabarzon and Metro Manila, where about 700,000 individuals received at least one dose of the vaccine. [11] The government paid P3.5-billion for the vaccine. [10]
Two types of dengue vaccine have been approved and are commercially available. Dengvaxia became available in 2016, but it is only recommended to prevent re-infection in individuals who have been previously infected. [13] The second vaccine, Qdenga, became available in 2022 and is suitable for adults, adolescents and children from four years of ...
Takeda's vaccine, branded as QDENGA, was authorized in the European Union last year for use in those aged 4 and older to prevent any of the four so-called serotypes of dengue. Takeda withdraws US ...
A new vaccine candidate was more than 83 percent effective at protecting against hospitalizations over a three-year clinical trial. Dengue virus is a mosquito-borne disease that can cause severe ...
President Rodrigo Duterte has said that he is open to lifting the ban on the anti-dengue vaccine Dengvaxia after the health department declared that the Philippines is in the midst of a national ...
The 2019–2020 dengue fever epidemic was an epidemic of the infectious disease dengue fever in several countries of Southeast Asia, including the Philippines, Malaysia, Vietnam, and Bangladesh, [1] Pakistan, [2] India, Thailand, Singapore, and Laos. [3]
The government had previously put the AstraZeneca vaccine in a parallel optional programme after reports of possible links to very rare blood clots. Malaysia grants conditional approval for Thai ...